Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03753542 |
|
Recruitment Status : Unknown
Verified February 2019 by Nomi Waqas Gul, Dow University of Health Sciences.
Recruitment status was: Active, not recruiting
First Posted : November 27, 2018
Last Update Posted : February 11, 2019
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
ABSTRACT
Background:
Today, a wide range of pediatric cancers is treated by chemotherapy. More than 21 side effects of chemotherapy have been identified. Among those nausea; vomiting, infection and anemia are most common. The adverse effects are normally managed by the parents at home. Ineffective coping and lack of knowledge about chemotherapy side effect management leads parents stress. Contemporary research evidence that Nurse-led education, booklet providence and follow up about chemotherapy and side effect management, help to decrease parents anxiety and depression.
Objectives:
To measure the effect of nurse-led multimedia education, booklet providence and telephonic follow up about chemotherapy and side effects management on parents anxiety and depression of children receiving chemotherapy for the first time.
Methodology:
A randomized control trial will be conducted in the department of chemotherapy at Indus Children Cancer Hospital Karachi from March 2018 to August 2018 on parents of children below 18 years of age undergoing chemotherapy for the first time. Total 100 parents will be randomly divided into Intervention group (n=50) and Control Group (n=50). The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management. The Control group will receive routine care. Parent's anxiety and depression will be identified by using DASS-21 and generalized estimating estimation will be used to analyzed the data.
Keywords:
Nurse-led, Multimedia education, Booklet, telephonic follow-up, chemotherapy, side effects, parents, anxiety, depression, children, cancer
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Chemotherapy Effect | Other: Multimedia education, booklet Providence and tele-nursing follow-up | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 2 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The sample size calculated was 30 samples per group. After adjusting error in non-response of data collection 50 samples will be drown from each group. Total 100 caregivers along with their children will be selected. |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy |
| Actual Study Start Date : | September 6, 2018 |
| Actual Primary Completion Date : | December 30, 2018 |
| Estimated Study Completion Date : | March 30, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention
The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management
|
Other: Multimedia education, booklet Providence and tele-nursing follow-up
Multimedia education, booklet and weekly tele-nursing follow-up is about chemotherapy and side effects management |
|
No Intervention: Control
The Control group will receive routine care
|
- Depression, Anxiety and Stress Scale - 21 (DASS-21) [ Time Frame: up to 4 weeks ]Depression (D) and anxiety (A) and stress(S) will be outcome variable. They will be identified by using DASS-21 Scale. The use of DASS-21 Scale is evident in Pakistan . There are 21 questions in this scale equally divided in to three parts having seven questions for Depression, Anxiety and stress respectively. Each question have four level of measurement 0,1, 2 and 3, represent past week experiences. 0 means not applicable to person, 1 means applicable to some degree or sometime, 2 means applicable to considerable degree or good part of time, 3 means applicable to person very much or most of the time. Each question is separate for Stress(s), Anxiety (a) and Depression (d).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | up to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Parents along with their children younger than 18 years of age
- Parents along with their children newly diagnosed with cancer in last three weeks
- Parents along with their children schedule to receive first time chemotherapy in the outpatient department
Exclusion Criteria:
- Parents along with their children refused to participate
- Parents along with their children already receiving interventions like multimedia education, booklet providence and telephonic follow up for chemotherapy and side effect management
- Parents taking medicine for their anxiety and depression. (e.g. Anxiolytics/ Antidepressant)
- Parents showing uneasiness and discomfort during educational session.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03753542
| Pakistan | |
| Indus Children Cancer Hospital Karachi | |
| Karachi, Sindh, Pakistan | |
| Study Chair: | Dr. Mehwish HUSSAIN, PhD (Statistics) | Senior Lecturer, DUHS, Karachi | |
| Study Chair: | Dr. SHAMVIL ASHRAF, MBBS, DCH, MCPS, FCPS, MRCP | Indus Hospital Karachi | |
| Study Chair: | Mr. Hakim Shah, MSN | Associate Professor Institute of Nursing Dow University of Health Sciences Karachi |
| Responsible Party: | Nomi Waqas Gul, Principal Investigator, Dow University of Health Sciences |
| ClinicalTrials.gov Identifier: | NCT03753542 |
| Other Study ID Numbers: |
Enr # 12/2015/912 |
| First Posted: | November 27, 2018 Key Record Dates |
| Last Update Posted: | February 11, 2019 |
| Last Verified: | February 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | No plan |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
chemotherapy, side effects, parents, anxiety, depression |
|
Depression Behavioral Symptoms |

